Methods to differentially label cell-surface and intracellular membrane proteins are indispensable for understanding their function and the regulation of their trafficking.
MAIN TEXT
Plasma membrane resident proteins are in charge of vital functions for cells and organisms. Membrane receptors relay external signals inside cells. Transporters are involved in the movement of ions, small molecules and macromolecules across the cell membrane. Cell adhesion molecules dictate how cells interact with other cells or with the extracellular matrix. Defects within the trafficking of membrane proteins are associated with many important diseases. Tools that enable simple and efficient study of the secretion, transportation and recycling of membrane proteins are thus fundamental for both understanding membrane protein functions and developing innovative cell assays for the discovery of small molecules able to restore genetic mutation-induced trafficking defects.
Discriminating a protein of interest at the cell-surface from the same protein inside cell requires effective and selective fluorescence labeling methods. Ideal fluorescent probes for labeling cell-surface proteins (i) are unable to cross membranes, and (ii) allow instantaneous and wash-free labeling in order to quantify cell-surface protein levels by simple add-and-read protocols. Rapid wash-free labeling protocols are crucial to minimize any artefactual events of secretion, transportation or recycling that could occur during the labeling and washing steps. In this context, the use of small fluorogenic probes that are membrane-impermeant and non-fluorescent until labeling occurs are thus highly attractive for labeling cell-surface membrane proteins.
Membrane-impermeant fluorogenic substrates for self-labeling tags such as SNAPtag 1-3 and PYP-tag 4 allowed wash-free covalent labeling of cell-surface fusion proteins.
These approaches requires however several tens of minutes for reaching In order to broaden the toolbox available for the study of membrane proteins, in particular in terms of spectral properties and tag size, we developed an approach based on a new generation of chemical-genetic fluorescent markers called FAST (fluorescence-activating and absorption-shifting tag), which has been recently developed for the selective labeling of fusion proteins in living cells 13 . FAST is a small 14 kDa protein tag evolved to form non-covalent and reversible fluorescent complexes with cell-permeant and non-toxic 4-hydroxybenzylidene rhodanine (HBR) analogs 13, 14 .
Because they fluoresce only when immobilized within FAST (because of conformational locking) and undergo an > 80 nm red-shift in absorption upon binding (due to selective binding of their anionic form), HBR analogs do not exhibit nonspecific fluorescence in cells, enabling to image without the need for washing. FAST was shown to be functional in various subcellular localizations and expression systems (e.g. bacteria, yeast, mammalian cells) including multicellular organisms (e.g. zebrafish embryo) 13 . An important feature of FAST is the ability to tune its properties by changing the chemical structure of the applied fluorogen 14 . To further extend its use for the selective detection of cell-surface proteins (Figure 1A) , we developed fluorogens able to form fluorescent complexes with FAST, but incapable of crossing the plasma membrane. These membrane-impermeant fluorogens allowed us to develop an efficient and simple add-and-read labeling protocol to study protein trafficking by various quantitative fluorometric techniques. HBR analogs are mainly neutral at physiological pH and highly membrane-permeant.
To prevent membrane crossing and restrain protein labeling to the cell surface, we introduced a negative charge by tethering a carboxymethyl group (deprotonated at physiological pH) to the rhodanine head ( Figure 1B) . As the brightness of FAST:fluorogen complexes depends furthermore on the ability of the protein cavity to lock the fluorogen in an emissive conformation, we synthesized carboxymethylated HBR analogs with various steric demands by varying the substituents on the aromatic ring ( Figure 1B and Figure S1 ). The synthesized carboxymethylated fluorogens (i) showed micromolar affinities for FAST compatible with efficient labeling in live cells, and (ii) formed fluorescent complexes with FAST ( Figure 1C and Table 1 ). As expected from other HBR analogs 13, 14 , upon binding to FAST the reported fluorogens underwent both a red-shift in absorption (of about 60 nm) due to specific binding of the deprotonated fluorogen and a large fluorescence increase (from 110 to 280-fold) that ensures high signal-to-background ratio ( Figure 1C and Table 1 ).
Based on its binding and brightness performance, we focused on HBRAA-3E for cell validation. We first showed that HBRAA-3E was non-toxic for mammalian cells by determining cell viability after 24 h of incubation ( Figure S2) . We next verified cell exclusion after prolonged exposure. We expressed FAST fused to the red fluorescent protein mCherry in the cytoplasm of HeLa cells. Cells were then incubated for two hours with media containing 5 µM HBRAA-3E. Confocal imaging revealed no intracellular labeling of FAST (Figure 2A) , attesting the cell exclusion of HBRAA-3E within this extended time window.
Next, we evaluated the selective labeling of cell-surface FAST-tagged proteins with HBRAA-3E. We transiently expressed in HeLa cells a secreted transmembrane FAST fusion protein sFASTtm1, which consists in FAST fused at the N-terminus to the murine Ig k-chain leader sequence and at the C-terminus to the platelet derived growth As HMBR binds FAST more tightly than HBRAA-3E, we anticipated that HMBR could dynamically replace bound HBRAA-3E, allowing one to detect and quantify in the same experiment the extracellular and the total pool of FAST-tagged protein ( Figure 2C ).
We previously demonstrated such replacement with fluorogens displaying different spectral properties 14 . As FAST:HMBR and FAST:HBRAA-3E could not be distinguished spectrally, we exploited the difference of brightness of the two complexes to demonstrate the replacement. Replacement of HBRAA-3E-containing cell medium with HMBR-containing cell medium led to an increase of membrane fluorescence in agreement with the higher brightness of FAST:HMBR ( Figure S3 ). To demonstrate complete replacement, cells were washed to unlabel FAST, and were next treated only with HMBR: this second HMBR addition led to fluorescence levels identical to those observed after the first HMBR addition (Figure S3 ), demonstrating that HMBR did replace HBRAA-3E dynamically.
Next, we analyzed labeling kinetics by time-lapse microscopy. Analysis of HeLa cells expressing sFASTtm1 showed that labeling of sFASTtm1 with 5 µM of HBRAA-3E was complete within 10 s ( Figure 2D ,E and Movie S1), which corresponds to our knowledge to one of the fastest kinetics ever reported for cell-surface protein labeling.
The fast labeling kinetics showed us that FAST was well suited for the development a simple add-and-read protocol for the quantification of cell-surface proteins. Next, we developed a protocol for the study of protein trafficking by flow cytometry. Flow cytometry has the advantage of enabling easy and unbiased statistical analysis with a higher throughput than microscopy. We anticipated that the ability to quantify in parallel the amount of surface protein with membrane impermeant HBRAA-3E and the total with Cycloheximide that blocks protein synthesis 16 . Cells were labeled by addition of HBRAA-3E or HMBR, and then directly analyzed by flow cytometry without washing.
Both Brefeldin A and Cycloheximide induced a two-fold decrease of surface sFASTtm2 accumulation revealed with HBRAA-3E ( Figure 3B) . By contrast, only Cycloheximide treatment impaired the total amount of sFASTtm2 quantified with membrane-permeant HMBR (Figure 3B) . This experiment illustrated how Brefeldin A specifically acts on protein trafficking, while Cycloheximide decreases the global protein pool irrespectively of its localization or trafficking property (Figure 3B) . Taken together, these results demonstrated that our approach enables to (i) screen for drugs impacting cell-surface protein secretion and (ii) discriminate between defects in protein trafficking or in protein synthesis/turnover. The discovery of small molecules able to restore trafficking defects induced by genetic mutations has become highly important in drug design 17 . Validating the ability of a small molecule to restore normal traffic requires spatial information that is classically provided by microscopy and image analysis, limiting thus screening throughput.
Methods to interrogate protein trafficking using technologies more suitable for high throughput analysis such as spectrofluorimetry or flow cytometry, are thus needed 18 .
To address the relevance of our strategy for screening drugs able to rescue cell-surface expression, we used the human D2 dopamine receptor (D2R) as a model of GPCR 11 . Mutations in the DRY motif at the end of the transmembrane-domain (TM)3
in GPCRs are known to contribute to diseases by (i) constitutive receptor activation and internalization, and (ii) retention of misfolded receptors in the endoplasmic reticulum (ER) [19] [20] [21] . D2R and a DRY-to-AAY D2R mutant (mutD2R) fused to an extracellular FAST were expressed in HeLa cells. We verified by confocal microscopy that cells labeled with membrane-impermeant HBRAA-3E showed membranelocalized FAST-D2R, while no fluorescence signal could be detected for FAST-mutD2R, in agreement with a trafficking defect (Figure S4 ). Subsequent addition of membrane-permeant HMBR revealed that FAST-mutD2R was retained in the ER as expected (Figure S4) . The cell surface accumulation of FAST-mutD2R could be rescued by addition of Spiperone, a D2R antagonist previously reported to act as pharmacological chaperone 11 (Figure S4 ). With this model system in hand, we next quantified the rescue of cell-surface FAST-mutD2R expression by flow cytometry.
Cells expressing FAST-D2R and FAST-mutD2R were labeled with either membraneimpermeant HBRAA-3E or membrane-permeant HMBR in order to determine the fraction of cell-surface expressed receptors. Flow cytometry analysis showed a tenfold lower cell-surface expression of FAST-mutD2R relative to wild-type FAST-D2R
( Figure 3C) , in agreement with a strong trafficking defect. Addition of Spiperone restored cell-surface FAST-mutD2R levels to wild-type ones (Figure 3C) . In addition, we evidenced that (i) part of the loss of cell-surface expression of mutD2R resulted from a two-fold reduction of the total mutD2R level, and that (ii) Spiperone restored normal level, possibly by preventing degradation through stabilization of the receptor upon ligand binding or by limiting aggregation. Taken together, these experiments demonstrated that the combined use of membrane-impermeant and membrane-permeant fluorogens was very well-suited to quantify trafficking restoration without the need for imaging, opening great prospects for high-throughput screening of small molecules able to correct genetic disorders of protein trafficking.
In this paper, we present a general method allowing the selective fluorescent labeling of cell-surface proteins. We used a small and versatile protein tag of 14 kDa, FAST, that forms a fluorescent complex with HBR analogs 13, 14 . Compared to other fluorogenic tagging systems such as FAPs, which are single-chain variable fragments of 25-30 kDa, FAST has the advantages of being disulfide-free and significantly smaller (only 14 kDa). Disulfide-free tags ensure full activity no matter the redox conditions and cell localization (which is crucial for proteins that traffic through various localizations), providing greater experimental versatility. The size of tags is, on the other hand, a general concern among biologists. Smaller tags are in general preferable as they minimize potential interference with protein localization and function. As the modular bipartite nature of the FAST:fluorogen interaction allows to modulate the properties of the genetically encoded FAST reporter by changing the structure of the applied fluorogen 14 , we functionalized HBR analogs with a negatively charged carboxymethyl group in order to prevent membrane crossing and restrain protein labeling to the cell surface. This singular property permits to obtain spatial information on FAST-tagged proteins by a simple measurement of fluorescence, without the need for microscopy and image analysis. We developed an efficient protocol to quantify the surface display level of FAST-tagged membrane proteins by flow cytometry, a method allowing high throughput statistical analysis. Compared to labor-intensive and multistep protocols based on immunostaining or covalent labeling, our fluorogenic approach boils down to a single addition of fluorogen to the cell suspension prior to the cytometry analysis, reducing the overall workflow to a single injection step. The ability to quantify both the surface display level and the total expression level enables to evaluate whether low surface expression results from changes in gene expression, protein synthesis, trafficking or degradation. We showed that our approach was well suited to evaluate the ability of small molecules to rescue trafficking defects by flow cytometry, opening great prospects for the design of high throughput screening assays for the discovery of drugs to treat trafficking related diseases.
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(Z)-2-(5-(4-hydroxy-3-methylbenzylidene)-4-oxo-2-thioxothiazolidin-3-yl)acetic acid (HBRAA-3M)
Yellow powder (80 %). 1 Shoreline, WA). The overall emission quantum yields after one-photon excitation were determined as previously described 2 . Affinity constants were determined by spectrofluorometric titration using a Spark 10M plate reader (Tecan) following protocols previously described 2 . Flow cytometry Cells were seeded at 125,000 cells per well. After 24 hours, cells were transfected and expression was induced with 0.5 µg/ml doxycyline for 24h.
Mammalian cell culture
Drugs or appropriate control were added to the culture medium either immediately for overnight treatment (Spiperone 10 µM, control = DMSO) or the next day 6 hours before harvesting (Brefeldine A 1 µg/mL, Cycloheximide 15 µg/mL, control = DMSO + ethanol). Cells were washed with PBS and harvested using 2mM EDTA in PBS.
After 3 minutes centrifugation at ~ 120 g, cells were resuspended in appropriate volume of ice-cold PBS containing a dye to detect cell death (TO-PRO 3, 1:1000, Invitrogen) and kept on ice. Samples were then separated into 2 tubes in which either cell-permeant fluorogen HMBR or cell-impermeant fluorogen HBRAA-3E was added just before cytometry analysis using a FACSCalibur cytometer (BD Biosciences). For the experiments on Figure 3B , the concentrations of HBRAA-3E and HMBR used for labeling were 50 µM and 5 µM, respectively. For the experiments on Figure 3C , the concentrations of HBRAA-3E and HMBR used for labeling were 5 µM and 5 µM, respectively. Acquisition and quantification made use of CELLQuest pro software (BD Biosciences). 
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